Using Quality Improvement Tools to Reduce Chronic Lung Disease

Alan Peter Picarillo1, Waldemar Carlo2

  • 1Maine Neonatology Associates, Barbara Bush Children's Hospital, Maine Medical Center, 22 Bramhall Street, Portland, ME 04102, USA.

Clinics in Perinatology
|August 14, 2017
PubMed

Insights

Rates of chronic lung disease in very low birthweight infants remain high. Quality improvement projects are essential for reducing this common neonatal morbidity, drawing on evidence and expert recommendations.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Quality Improvement Science

Background:

  • Chronic lung disease (CLD) rates in very low birthweight infants have stagnated compared to other neonatal morbidities over the last two decades.
  • The multifactorial etiology of CLD presents challenges for effective reduction strategies.
  • Quality improvement (QI) projects are increasingly recognized as crucial in neonatal care.

Purpose of the Study:

  • To highlight the persistent challenge of chronic lung disease in very low birthweight infants.
  • To underscore the importance of evidence-based quality improvement initiatives in neonatal intensive care units.

Main Methods:

  • Review of medical literature and expert recommendations for CLD management.
  • Analysis of successful quality improvement projects in neonatal intensive care units.
  • Synthesis of best practices for developing targeted CLD reduction strategies.

Main Results:

  • Chronic lung disease rates have not seen the same decline as other neonatal morbidities.
  • Successful QI projects demonstrate the potential for reducing CLD incidence.
  • A structured approach to QI is necessary for impactful outcomes.

Conclusions:

  • Addressing chronic lung disease in very low birthweight infants requires focused, evidence-based quality improvement efforts.
  • Individualized QI projects, informed by literature and expert consensus, are vital for neonatal care advancement.
  • Continued research and implementation of QI initiatives are necessary to improve outcomes for vulnerable infants.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.3K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
907
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.2K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.7K